Clinical Trials in Denver

Showing 12221-12240 of 15,604 trials

Open Label, Phase I ZD6474 Head and Neck Cancer Study

NCT00450138

The purpose of this study is to determine the maximum tolerated dose of ZD6474 given in combination with radiation or in combination with chemotherapy and radiation in patients with squamous cell carcinoma of the head and neck.

Head and Neck Cancer

Sanofi48 participantsStarted Dec 2006

Denver, Colorado, United States • Chicago, Illinois, United States • Dallas, Texas, United States +1 more locations

COMPLETEDPhase 36.3 miles

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)

NCT01358864

The aim of this trial is to evaluate the efficacy and the safety of BI 201335 given for 12 or 24 weeks in combination with PegIFN/RBV given for 48 weeks as compared to PegIFN/RBV alone in chronic GT-1 hepatitis C virus infected patients who failed a prior PegIFN/RBV treatment.

Hepatitis C, Chronic

Boehringer Ingelheim678 participantsStarted Jun 2011

North Little Rock, Arkansas, United States • Englewood, Colorado, United States • Palm Harbor, Florida, United States +113 more locations

Open Label, Phase I ZD6474 Head and Neck Cancer Study

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)

Find Trials by Condition in Denver

Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors

Outpatient Pump Shutoff Pilot Feasibility and Efficacy Study

Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children

An Outpatient Pump Shutoff Pilot Feasibility and Safety Study

Bipolar Study in Adults at Least 18 Years of Age

Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal Polyps

Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa

HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects

A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers

Robotic-assisted Versus Laparoscopic Sigmoid Resection

Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients

Sensor Optimization of Cardiac Resynchronization Therapy Response

Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control

Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73

A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism